Reference health

Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention

https://doi.org/10.1007/978-3-030-43032-0_15
CiteStamped reference-health badge
2 of 30 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1200/JCO.2007.14.9401.Anthracycline
does not resolve to a known work10.11648/j.ijcocr.20170202.12
The 28 checked references that resolve
resolves10.1007/s10557-016-6711-0
Anthracycline Chemotherapy and Cardiotoxicity
resolves10.1146/annurev-biochem-061809-100002
New Mechanistic and Functional Insights into DNA Topoisomerases
resolves10.1146/annurev.biochem.70.1.369
DNA Topoisomerases: Structure, Function, and Mechanism
resolves10.1038/clpt.2013.201
Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
resolves10.5483/bmbrep.2006.39.6.759
Nitric Oxide Synthase Expressions in ADR-induced Cardiomyopathy in Rats
resolves10.4103/0973-7847.70902
Free radicals, antioxidants and functional foods: Impact on human health
resolves10.59566/IJBS.2008.4089
Free Radicals, Antioxidants in Disease and Health
resolves10.1093/jn/134.11.3143S
Executive Summary Report
resolves10.1016/j.jacc.2014.06.1167
Prevention of Anthracycline-Induced Cardiotoxicity
resolves10.21037/tcr.2018.04.24
Anthracycline cardiotoxicity: new actors on the stage
resolves10.1007/978-3-319-43096-6_2
Cardiotoxicity of Anticancer Therapies
resolves10.1007/s11897-012-0083-y
Chemotherapy-Induced Cardiotoxicity
resolves10.1038/nrdp.2017.58
Heart failure with reduced ejection fraction
resolves10.1007/s12410-012-9163-3
Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography
resolves10.1007/s11936-018-0641-z
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
resolves10.15420/cfr.2018.25.1
Subclinical Left Ventricular Dysfunction During Chemotherapy
resolves10.1186/s40169-017-0148-3
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
resolves10.1016/j.ejphar.2017.10.043
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
resolves10.2174/157340311799960645
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
resolves10.1172/JCI72931
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
resolves10.3389/fphar.2018.01262
Updates in Anthracycline-Mediated Cardiotoxicity
resolves10.1016/j.yjmcc.2012.03.006
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
resolves10.1021/tx000013q
Doxorubicin Metabolism and Toxicity in Human Myocardium:  Role of Cytoplasmic Deglycosidation and Carbonyl Reduction
resolves10.1016/j.ijcha.2015.11.004
Doxorubicin induced heart failure: Phenotype and molecular mechanisms
resolves10.1016/j.taap.2016.01.006
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity
resolves10.2147/CMAR.S47238
Dexrazoxane for the treatment of chemotherapy-related side effects
resolves10.1186/s40959-019-0036-7
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
resolves10.1097/MPH.0000000000001112
Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity
The 3 references without a DOI — listed, not checked
no DOI — not checkedYang F, Teves SS, Kemp CJ, Henikoff S (2014) Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta 1845(1):84–89
no DOI — not checkedSantos DS, Goldenberg RCS (2018) Doxorubicin-induced cardiotoxicity: from mechanisms to development of efficient therapy (Chapter 1). Cardiotoxicity: Intech Open, pp 3–24
no DOI — not checkedMinotti G, Salvatorelli E, Menna P, Ronchi R, Cairo G (2001) Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res 61(23):8422–8428
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1007/978-3-030-43032-0_15"><img src="https://citestamp.com/citestamped/10.1007/978-3-030-43032-0_15/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1007/978-3-030-43032-0_15/badge.svg)](https://citestamp.com/citestamped/10.1007/978-3-030-43032-0_15)